Skip to main content
Top
Published in: Drug Safety 5/2005

01-05-2005 | Original Research Article

Detecting Adverse Drug Reactions on Paediatric Wards

Intensified Surveillance Versus Computerised Screening of Laboratory Values

Authors: Steffen Haffner, Nicoletta von Laue, Stefan Wirth, Professor Petra A. Thürmann

Published in: Drug Safety | Issue 5/2005

Login to get access

Abstract

Background: Adverse drug reactions (ADRs) contribute significantly to patient morbidity and mortality, as well as to costs for healthcare systems. Our aim was to evaluate the type and incidence of ADRs in a paediatric hospital population, comparatively ascertained by two different methodological approaches.
Methods: Our prospective study enrolled all patients admitted to two of the general children wards (46 beds) and the paediatric intensive care unit (6 beds) at the HELIOS Klinikum Wuppertal teaching hospital in Germany, over the study period of 3 months. We used two methods to detect ADRs. The intensified surveillance system relied on a trained physician conducting ward rounds and assessing patient charts. The computer-assisted screening of pathological laboratory parameters used values slightly below or above the age-specific normal range as a trigger signal for a potential ADR, which was subsequently assessed by trained personnel.
Results: By applying both methods simultaneously we observed that 14.1% of children experienced an ADR while they were hospitalised and 2.7% of children were admitted to hospital because of the ADR. Intensified surveillance resulted in the detection of 101 ADRs in 11.9% of patients, predominantly presenting with gastrointestinal symptoms, skin and CNS disorders; computer-assisted screening identified 45 ADRs in 5.7% of patients, mainly with drug-induced blood dyscrasia and liver damage. Furthermore, the ADRs detected by the intensified method were more severe, affected younger children and showed a closer causal attributability to the reaction than the ADRs observed by the computerised method. The spectra of drugs involved were similar, with the anti-infectives being suspected most frequently. The sensitivities of the intensified surveillance system and the computerised surveillance screening came to 67.2% and 44.8%, respectively, with computer-assisted screening having a specificity of 72.8%. The mean positive predictive value of the pathological laboratory values under surveillance by computer-assisted screening was 18.6%. Approximately 25% of ADR-related drugs administered were used for off-label indications.
Conclusion: Using the published literature for comparison, we found that ADRs occur as frequently in paediatric patients as in adult patients. Intensified surveillance and computerised surveillance applied in the paediatric setting show substantial differences in their detection specificities. A higher number of and more severe ADRs can be detected by intensified surveillance than by computerised surveillance, but require higher personnel resources.
Literature
1.
go back to reference Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277: 307–11PubMedCrossRef Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277: 307–11PubMedCrossRef
2.
go back to reference Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277: 301–6PubMedCrossRef Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277: 301–6PubMedCrossRef
3.
go back to reference Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5PubMedCrossRef Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5PubMedCrossRef
4.
go back to reference Impicciatore P, Choonara I, Clarkson A, et al. Incidence of adverse drug reactions in pediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001; 52: 77–83PubMedCrossRef Impicciatore P, Choonara I, Clarkson A, et al. Incidence of adverse drug reactions in pediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001; 52: 77–83PubMedCrossRef
5.
go back to reference McKenzie MW, Stewart RB, Weiss CF, et al. A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm 1973; 30: 898–903PubMed McKenzie MW, Stewart RB, Weiss CF, et al. A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm 1973; 30: 898–903PubMed
6.
go back to reference Whyte J, Greenan E. Drug usage and adverse drug reactions in pediatric patients. Acta Paediatr Scand 1977; 66: 767–75PubMedCrossRef Whyte J, Greenan E. Drug usage and adverse drug reactions in pediatric patients. Acta Paediatr Scand 1977; 66: 767–75PubMedCrossRef
7.
go back to reference Mitchell AA, Goldman P, Shapiro S, et al. Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol 1979; 110: 196–204PubMed Mitchell AA, Goldman P, Shapiro S, et al. Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol 1979; 110: 196–204PubMed
8.
go back to reference Choonara IA, Harris F. Adverse drug reactions in medical inpatients. Arch Dis Child 1984; 59: 578–80PubMedCrossRef Choonara IA, Harris F. Adverse drug reactions in medical inpatients. Arch Dis Child 1984; 59: 578–80PubMedCrossRef
9.
go back to reference Easton KL, Parsons BJ, Starr M, et al. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust 1998; 169: 356–9PubMed Easton KL, Parsons BJ, Starr M, et al. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust 1998; 169: 356–9PubMed
10.
go back to reference Martinez-Mir I, Garcia-Lopez M, Palop V, et al. A prospective study of adverse drug reactions as a cause of admission to a pediatric hospital. Br J Clin Pharmacol 1996; 42: 319–24PubMedCrossRef Martinez-Mir I, Garcia-Lopez M, Palop V, et al. A prospective study of adverse drug reactions as a cause of admission to a pediatric hospital. Br J Clin Pharmacol 1996; 42: 319–24PubMedCrossRef
11.
go back to reference Thuermann P. Methods and systems to detect adverse drug reactions in hospital. Drug Saf 2001; 24: 961–8CrossRef Thuermann P. Methods and systems to detect adverse drug reactions in hospital. Drug Saf 2001; 24: 961–8CrossRef
12.
go back to reference Dormann H, Muth-Selbach U, Krebs S, et al. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf 2000; 22: 161–8PubMedCrossRef Dormann H, Muth-Selbach U, Krebs S, et al. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf 2000; 22: 161–8PubMedCrossRef
13.
go back to reference Levy M, Azaz-Livshits T, Sadan B, et al. Computerized survelliance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol 1999; 54: 887–92PubMedCrossRef Levy M, Azaz-Livshits T, Sadan B, et al. Computerized survelliance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol 1999; 54: 887–92PubMedCrossRef
14.
go back to reference Classen DC, Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991; 266: 2847–51PubMedCrossRef Classen DC, Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991; 266: 2847–51PubMedCrossRef
15.
go back to reference Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA 1998; 280: 1317–20PubMedCrossRef Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA 1998; 280: 1317–20PubMedCrossRef
16.
go back to reference Impicciatore P, Choonara I. Status of new medicines approved by the European Medicines Evaluation Agency regarding pediatric use. Br J Clin Pharmacol 1999; 48: 15–8PubMedCrossRef Impicciatore P, Choonara I. Status of new medicines approved by the European Medicines Evaluation Agency regarding pediatric use. Br J Clin Pharmacol 1999; 48: 15–8PubMedCrossRef
17.
go back to reference Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in pediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 2000; 320: 79–82PubMedCrossRef Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in pediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 2000; 320: 79–82PubMedCrossRef
18.
go back to reference Turner S, Nunn AJ, Fielding K, et al. Adverse drug reactions to unlicensed and off-label drugs on pediatric wards: a prospective study. Acta Paediatr 1999; 88: 965–8PubMedCrossRef Turner S, Nunn AJ, Fielding K, et al. Adverse drug reactions to unlicensed and off-label drugs on pediatric wards: a prospective study. Acta Paediatr 1999; 88: 965–8PubMedCrossRef
19.
go back to reference Weiss J, Krebs S, Hoffmann C, et al. Survey of adverse drug reactions on a pediatric ward: a strategy for early and detailed detection. Pediatrics 2002; 110: 254–7PubMedCrossRef Weiss J, Krebs S, Hoffmann C, et al. Survey of adverse drug reactions on a pediatric ward: a strategy for early and detailed detection. Pediatrics 2002; 110: 254–7PubMedCrossRef
20.
go back to reference Thuermann PA, Windecker R, Steffen J, et al. Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach. Drug Saf 2002; 25: 713–24PubMedCrossRef Thuermann PA, Windecker R, Steffen J, et al. Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach. Drug Saf 2002; 25: 713–24PubMedCrossRef
21.
go back to reference Benichou C. Criteria of drug-induced liver disorders: report of an international consensus meeting. J Hepatol 1990; 11: 272–6PubMedCrossRef Benichou C. Criteria of drug-induced liver disorders: report of an international consensus meeting. J Hepatol 1990; 11: 272–6PubMedCrossRef
22.
go back to reference Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–9PubMedCrossRef Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–9PubMedCrossRef
23.
go back to reference BPI Service GmbH: Fach Info-Service (SPCs) Deutschland. Bundesverband der Pharmazeutischen Industrie [online]. Available from URL: http://www.fachinfo.de [Accessed 2004 Feb 24] BPI Service GmbH: Fach Info-Service (SPCs) Deutschland. Bundesverband der Pharmazeutischen Industrie [online]. Available from URL: http://​www.​fachinfo.​de [Accessed 2004 Feb 24]
24.
go back to reference Thomson Corporation. Thomson Micromedex® Healthcare Series 2001, Vol. 108, 2001 [online]. Available from URL: http://www.micromedex.com [Accessed 2004 Feb 24] Thomson Corporation. Thomson Micromedex® Healthcare Series 2001, Vol. 108, 2001 [online]. Available from URL: http://​www.​micromedex.​com [Accessed 2004 Feb 24]
25.
go back to reference Schosser R, Quast U. Verdacht auf Nebenwirkungen: Medizinische Uberlegungen zur Kausalitat. Pharm Ind 1998; 60: 185–91 Schosser R, Quast U. Verdacht auf Nebenwirkungen: Medizinische Uberlegungen zur Kausalitat. Pharm Ind 1998; 60: 185–91
26.
go back to reference Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. In: Davies DM, editor. Textbook of adverse drug reactions. Oxford: Oxford University Press, 1991: 18–45 Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. In: Davies DM, editor. Textbook of adverse drug reactions. Oxford: Oxford University Press, 1991: 18–45
27.
go back to reference Vazquez de la Villa A, Luna del Castillo JD, Galdo Munoz G, et al. Adverse reactions caused by drugs in pediatrics [Spanish]. An Esp Pediatr 1989; 31: 49–53 Vazquez de la Villa A, Luna del Castillo JD, Galdo Munoz G, et al. Adverse reactions caused by drugs in pediatrics [Spanish]. An Esp Pediatr 1989; 31: 49–53
28.
go back to reference Gonzalez-Martin G, Caroca CM, Paris E. Adverse drug reactions (ADRs) in hospitalized pediatric patients: a prospective study. Int J Clin Pharmacol Ther 1998; 36: 530–3PubMed Gonzalez-Martin G, Caroca CM, Paris E. Adverse drug reactions (ADRs) in hospitalized pediatric patients: a prospective study. Int J Clin Pharmacol Ther 1998; 36: 530–3PubMed
29.
go back to reference Martinez-Mir I, Garcia-Lopez M, Palop V, et al. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 1999; 47: 681–8PubMedCrossRef Martinez-Mir I, Garcia-Lopez M, Palop V, et al. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 1999; 47: 681–8PubMedCrossRef
30.
go back to reference Mitchell AA, Lacouture PG, Sheehan JE, et al. Adverse drug reactions in children leading to hospital admission. Pediatrics 1988; 82: 24–9PubMed Mitchell AA, Lacouture PG, Sheehan JE, et al. Adverse drug reactions in children leading to hospital admission. Pediatrics 1988; 82: 24–9PubMed
31.
go back to reference Yosselson-Superstine S, Weiss T. Drug-related hospitalization in pediatric patients. J Clin Hosp Pharm 1982; 7: 195–203PubMed Yosselson-Superstine S, Weiss T. Drug-related hospitalization in pediatric patients. J Clin Hosp Pharm 1982; 7: 195–203PubMed
32.
go back to reference McKenzie MW, Marchall GL, Netzloff ML, et al. Adverse drug reactions leading to hospitalization in children. J Pediatr 1976; 89: 487–90PubMedCrossRef McKenzie MW, Marchall GL, Netzloff ML, et al. Adverse drug reactions leading to hospitalization in children. J Pediatr 1976; 89: 487–90PubMedCrossRef
33.
go back to reference Bonati M, Marchetti F, Zullini MT, et al. Adverse drug reactions in neonatal intensive care units. Adverse Drug React Acute Poisoning Rev 1990; 9: 103–18PubMed Bonati M, Marchetti F, Zullini MT, et al. Adverse drug reactions in neonatal intensive care units. Adverse Drug React Acute Poisoning Rev 1990; 9: 103–18PubMed
34.
go back to reference Aranda JV, Portuguez-Malavasi A, Collinge JM, et al. Epidemiology of adverse drug reactions in the newborn. Dev Pharmacol Ther 1982; 5: 173–84PubMed Aranda JV, Portuguez-Malavasi A, Collinge JM, et al. Epidemiology of adverse drug reactions in the newborn. Dev Pharmacol Ther 1982; 5: 173–84PubMed
35.
go back to reference Gill AM, Leach HJ, Hughes J, et al. Adverse drug reactions in a pediatric intensive care unit. Acta Paediatr 1995; 84: 438–41PubMedCrossRef Gill AM, Leach HJ, Hughes J, et al. Adverse drug reactions in a pediatric intensive care unit. Acta Paediatr 1995; 84: 438–41PubMedCrossRef
36.
go back to reference Dharnidharka VR, Kandoth P. Pediatric inpatient morbidity patterns and drug usage in a teaching hospital serving an underdeveloped area. Indian J Public Health 1999; 43: 64–6PubMed Dharnidharka VR, Kandoth P. Pediatric inpatient morbidity patterns and drug usage in a teaching hospital serving an underdeveloped area. Indian J Public Health 1999; 43: 64–6PubMed
37.
go back to reference Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001; 285: 2114–20PubMedCrossRef Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001; 285: 2114–20PubMedCrossRef
38.
go back to reference Thomas EJ, Lipsitz SR, Studdert DM, et al. The reliability of medical record review for estimating adverse event rates. Ann Intern Med 2002; 136: 812–6PubMed Thomas EJ, Lipsitz SR, Studdert DM, et al. The reliability of medical record review for estimating adverse event rates. Ann Intern Med 2002; 136: 812–6PubMed
39.
40.
go back to reference Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in pediatric outpatients. Br J Clin Pharmacol 2002; 54: 665–70PubMedCrossRef Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in pediatric outpatients. Br J Clin Pharmacol 2002; 54: 665–70PubMedCrossRef
41.
go back to reference Neubert A, Dormann H, Weiss J, et al. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 2004; 27: 1059–67PubMedCrossRef Neubert A, Dormann H, Weiss J, et al. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 2004; 27: 1059–67PubMedCrossRef
42.
go back to reference t’Jong GW, van der Linden PD, Bakker EM, et al. Unlicensed and off-label drug use in a pediatric ward of a general hospital in the Netherlands. Eur J Clin Pharmacol 2002; 58: 293–7CrossRef t’Jong GW, van der Linden PD, Bakker EM, et al. Unlicensed and off-label drug use in a pediatric ward of a general hospital in the Netherlands. Eur J Clin Pharmacol 2002; 58: 293–7CrossRef
43.
go back to reference Andrews LB, Stocking C, Krizek T, et al. An alternative strategy for studying adverse events in medical care. Lancet 1997; 349: 309–13PubMedCrossRef Andrews LB, Stocking C, Krizek T, et al. An alternative strategy for studying adverse events in medical care. Lancet 1997; 349: 309–13PubMedCrossRef
Metadata
Title
Detecting Adverse Drug Reactions on Paediatric Wards
Intensified Surveillance Versus Computerised Screening of Laboratory Values
Authors
Steffen Haffner
Nicoletta von Laue
Stefan Wirth
Professor Petra A. Thürmann
Publication date
01-05-2005
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 5/2005
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200528050-00008

Other articles of this Issue 5/2005

Drug Safety 5/2005 Go to the issue